Showing results (71-80 of 125) with videos related to
Sort By:
Pageof 13
Cancer Research|March 26, 2009
The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinomaTanguy Y Seiwert, Ramasamy Jagadeeswaran, Leonardo Faoro, et al.Molecular Cancer Therapeutics|October 11, 2013
Molecular predictors of sensitivity to the insulin-like growth factor 1 receptor inhibitor Figitumumab (CP-751,871)Adam Pavlicek, Maruja E Lira, Nathan V Lee, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinibJochen K Lennerz, Eunice L Kwak, Allison Ackerman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2022
First-in-Human Phase I/IB Dose-Finding Study of Adagrasib (MRTX849) in Patients With Advanced KRAS Solid Tumors (KRYSTAL-1)Sai-Hong Ignatius Ou, Pasi A Jänne, Ticiana A Leal, et al.Cancer Research|November 7, 2023
TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C InhibitorsA Cole Edwards, Clint A Stalnecker, Alexis Jean Morales, et al.Biorxiv : the Preprint Server for Biology|October 9, 2023
Alveolar differentiation drives resistance to KRAS inhibition in lung adenocarcinomaZhuxuan Li, Xueqian Zhuang, Chun-Hao Pan, et al.Future Oncology (London, England)|November 8, 2024
Sitravatinib in patients with solid tumors selected by molecular alterations: results from a Phase Ib studyLyudmila Bazhenova, Dong-Wan Kim, Byoung Chul Cho, et al.Anticancer Research|July 31, 2013
PD-0332991, a potent and selective inhibitor of cyclin-dependent kinase 4/6, demonstrates inhibition of proliferation in renal cell carcinoma at nanomolar concentrations and molecular markers predict for sensitivityJoshua E Logan, Nikayeh Mostofizadeh, Amrita J Desai, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2011
[(18)F]FLT-PET imaging does not always "light up" proliferating tumor cellsCathy C Zhang, Zhengming Yan, Wenlin Li, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2010
PF-03732010: a fully human monoclonal antibody against P-cadherin with antitumor and antimetastatic activityCathy C Zhang, Zhengming Yan, Qin Zhang, et al.Pageof 13